Köse, D. Et Al. 2021. Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties. JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.73, no.10 , 1302-1309.

Köse, D., Ün, H., Uğan, R. A., Halıcı, Z., Çadırcı, E., Bal, T., ... Kahramanlar, A.(2021). Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties. JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.73, no.10, 1302-1309.

Köse, Duygu Et Al. "Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties," JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.73, no.10, 1302-1309, 2021

Köse, Duygu Et Al. "Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties." JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.73, no.10, pp.1302-1309, 2021

Köse, D. Et Al. (2021) . "Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties." JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.73, no.10, pp.1302-1309.

@article{article, author={Duygu KÖSE Et Al. }, title={Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties}, journal={JOURNAL OF PHARMACY AND PHARMACOLOGY}, year=2021, pages={1302-1309} }